openPR Logo
Press release

Influenza Pipeline Drugs 2024 | Moderna, SAB Biotherapeutics, ENA Respiratory Pty Ltd, Codagenix, AlloVir, Osivax, CureVac AG

08-26-2024 11:12 PM CET | Health & Medicine

Press release from: ABNewswire

Influenza Pipeline Drugs 2024 | Moderna, SAB Biotherapeutics,

DelveInsight's, "Influenza Pipeline Insight 2024" report provides comprehensive insights about 120+ companies and 120+ pipeline drugs in Influenza pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Discover the latest drugs and treatment options in the Influenza Pipeline. Dive into DelveInsight's comprehensive report today! @ Influenza Pipeline Outlook [https://www.delveinsight.com/sample-request/influenza-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]

Key Takeaways from the Influenza Pipeline Report

* August 2024:- Hoffmann-La Roche- A Phase IIIb Multicenter, Single-Arm, Open-Label Surveillance Study of Susceptibility to Baloxavir Marboxil in Patients With Influenza. The purpose of this study is to evaluate the pre-treatment and single-dose post treatment susceptibility of baloxavir marboxil in participants aged 1 to
* August 2024:- Janssen Vaccines & Prevention B.V.- A Randomized, Double-blind, Placebo-controlled, First-in-human Phase 1/2a Study to Evaluate Safety, Reactogenicity and Immunogenicity of a Universal Influenza (Uniflu) Vaccine With INFLUENZA G1 mHA in Healthy Adults. The primary purpose of this study is to evaluate safety/ reactogenicity of INFLUENZA G1 mini-hemagglutinin stem-derived protein vaccine antigen (mHA), with or without Al(OH)3 adjuvant, in healthy adults greater than or equal to (>=) 18 to less than or equal to (



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Influenza Pipeline Drugs 2024 | Moderna, SAB Biotherapeutics, ENA Respiratory Pty Ltd, Codagenix, AlloVir, Osivax, CureVac AG here

News-ID: 3635365 • Views:

More Releases from ABNewswire

Catawba Valley Psychiatry Clinic Opens in Hickory, Introduces Sliding Scale Payment for Uninsured Patients
Catawba Valley Psychiatry Clinic Opens in Hickory, Introduces Sliding Scale Paym …
Catawba Valley Psychiatry Clinic has opened in Hickory, NC, offering psychiatric care for adults and adolescents with depression, anxiety, ADHD, and mood disorders. The clinic accepts most major insurance plans and offers sliding scale payment options for uninsured patients and those facing financial hardship. Catawba Valley Psychiatry Clinic has opened in Hickory, offering evidence-based psychiatric care for adults and adolescents across the Catawba Valley region. The clinic provides treatment for depression,
Dry Eye Disease Market: Rapid Increment Driven by Innovation by 2034 - DelveInsight | Palatin Technologies, Novaliq, mc2 therapeutics
Dry Eye Disease Market: Rapid Increment Driven by Innovation by 2034 - DelveInsi …
The Key Dry Eye Disease Companies in the market include - Palatin Technologies, Novaliq, mc2 therapeutics, and others. The Dry Eye Disease market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Dry Eye Disease pipeline products will significantly revolutionize the Dry Eye Disease market dynamics. DelveInsight's "Dry Eye Disease Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding
Paroxysmal Nocturnal Hemoglobinuria Market: Expanding Revenue Landscape to 2034 - DelveInsight | Alexion Pharma, Hoffmann-La Roche, Novartis, Regeneron Pharma, AKARI Therapeutics, AstraZeneca
Paroxysmal Nocturnal Hemoglobinuria Market: Expanding Revenue Landscape to 2034 …
The Key Paroxysmal Nocturnal Hemoglobinuria Companies in the market include - Hoffmann-La Roche (Chugai Pharmaceutical), AstraZeneca (Alexion Pharmaceuticals), Apellis Pharmaceuticals, Swedish Orphan Biovitrum, Regeneron, Pharmaceuticals, Alnylam Pharmaceuticals, Omeros Corporation, BioCryst Pharmaceuticals, Novartis, Chengdu Suncadia Medicine Co., Ltd., Wuhan Createrna Science, Regeneron Pharma, Kira Pharma, NovelMed Therapeutics, and others. DelveInsight's "Paroxysmal Nocturnal Hemoglobinuria Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Paroxysmal Nocturnal Hemoglobinuria, historical and forecasted
SensePass Named Best Payment Orchestration Platform in 2026 for Enterprise and High-Volume Commerce
SensePass Named Best Payment Orchestration Platform in 2026 for Enterprise and H …
SensePass has been named the Best Payment Orchestration Platform in 2026, recognized for enterprise-grade scalability and high-volume global commerce. Supporting 100+ payment service providers, including credit card processors, BNPL, digital wallets, ACH, and crypto, and integrating with 30+ ERP, POS, and e-commerce platforms, SensePass delivers unmatched flexibility and centralized payment control. New York - SensePass announced it has been named the Best Payment Orchestration Platform in 2026, recognizing its leadership in

All 5 Releases


More Releases for Influenza

Multivalent Influenza Vaccines Market Advancing Influenza Prevention Strategies …
The "Multivalent Influenza Vaccines Market" research report represents major insights on the current growth dynamics as well as the primary revenue generation elements that are available in the Multivalent Influenza Vaccines industry along with various other factors over the predicted period 2024-2030. The report on the Multivalent Influenza Vaccines market is focusing on a series of parameters including top manufacturing strategies, industry share, prime opportunities, industrial channels, profit margin, etc.
Influenza Diagnostics Market - Rapid Detection, Effective Protection: Influenza …
Newark, New Castle, USA: The "Influenza Diagnostics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Influenza Diagnostics Market: https://www.growthplusreports.com/report/influenza-diagnostics-market/8780 This latest report researches the industry structure, sales, revenue,
Influenza Medication Market - Fight off the influenza virus with effective and r …
Newark, New Castle, USA: The "Influenza Medication Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Influenza Medication Market: https://www.growthplusreports.com/report/influenza-medication-market/7859 This latest report researches the industry structure, sales, revenue,
Influenza Medication Market - Revolutionizing Flu Treatment: Innovating Advanced …
Newark, New Castle, USA - new report, titled Influenza Medication Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Influenza Medication market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Influenza Medication market. The report offers an overview of the market, which
Influenza Vaccines Market - Empowering Strength, Nurturing Immunity: Innovating …
Newark, New Castle, USA - new report, titled Influenza Vaccines Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Influenza Vaccines market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Influenza Vaccines market. The report offers an overview of the market, which
H1N1 Influenza (Swine Influenza) Market to Witness Growth by 2032, Estimates Del …
DelveInsight's "H1N1 Influenza (Swine Influenza) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of H1N1 Influenza (Swine Influenza), historical and forecasted epidemiology as well as the H1N1 Influenza (Swine Influenza) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The H1N1 Influenza (Swine Influenza) market report provides current treatment practices, emerging drugs, the market share of the individual therapies,